课题基金 / 基金详情

Using Electronic Health Records from a Large Clinical Data Research Network to Understand Cancer Burden and Cancer Risks Among Transgender and Gender Nonconforming (TGNC) Individuals

Using Electronic Health Records from a Large Clinical Data Research Network to Understand Cancer Burden and Cancer Risks Among Transgender and Gender Nonconforming (TGNC) Individuals
使用来自大型临床数据研究网络的电子健康记录来了解跨性别者和性别不合格 (TGNC) 个体的癌症负担和癌症风险
批准号:
10056679
负责人:
Jiang Bian
金额:
$39.21万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-01 至 2024-01-31

项目摘要

项目成果

Jiang Bian的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 跨性别者和性别不合格者 (TGNC) 面临着不成比例的不良健康负担 结果。尽管关于 TGNC 独特健康问题的文献越来越多 但由于现有 TGNC 健康数据稀缺,他们的服务仍然严重不足。少报 由于与社会和经济边缘化、耻辱和歧视相关的问题,这种现象很常见,导致 由于 TGNC 个体往往不愿意自我认同,因此在获得基于人群的估计方面面临挑战 不愿意参与传统调查。此外,过去的 TGNC 研究主要集中在 心理健康、药物使用和滥用以及性传播感染和疾病。数据有限 适用于与年龄相关的慢性疾病,例如癌症,这是美国第二大死因 国家。尽管如此,癌症仍然是 TGNC 人群的首要研究重点之一。随着迅速 随着 TGNC 人口老龄化的加剧,迫切需要描述这些人群的癌症负担 个体,并了解与非 TGNC 个体相比,癌症对他们的影响有何不同。上 另一方面,电子健康记录(EHR)系统的快速采用使得纵向临床数据 可供研究。电子病历不仅包含重要的结构化数据,例如人口统计、诊断、 程序和药物,还包括非结构化的临床叙述,例如医生的笔记。超过80个 % 的临床信息记录在临床叙述中,其中包含更详细的患者信息 信息包括性别认同和癌症风险因素。受到这些观察的启发并建立在 我们之前的研究涉及 1) TGNC 性别认同术语的充分性,2) 临床自然语言 信息提取的处理方法,以及 3)基于 EHR 的队列研究,我们建议进行一项 基于人群的队列分析,使用以下方法检查 TGNC 人群的癌症负担和危险因素: 来自大型 EHR 网络的独特数据源 — OneFlorida,PCORI 资助的 13 个临床数据之一 为 PCORnet 做出贡献的研究网络 (CDRN)。使用结构化和非结构化 OneFlorida 数据,我们将首先开发可计算的表型来识别 TGNC 个体,然后评估他们的 癌症风险。我们的研究意义重大,因为:1)没有关于癌症风险的基于人群的队列研究 在 TGNC 人群中进行。我们的结果将支持定制的、证据的开发 针对 TGNC 人群的癌症筛查计划; 2) 我们的研究将创建一群 TGNC 人员, 不仅可以在 EHR 中进行纵向追踪,还可以招募用于未来的临床研究; 3)与 PCORnet CDRN 使我们的分析框架可推广到整个 PCORNet。总体而言,建议 研究将增进我们对老龄化 TGNC 人群癌症的了解。
英文摘要
ABSTRACT Transgender and gender nonconforming (TGNC) people face a disproportionate burden of adverse health outcomes. Although there is a growing body of literature on the unique health issues among TGNC populations, they remain severely underserved as existing data on TGNC health are scarce. Under-reporting is common due to issues related to social and economic marginalization, stigma, and discrimination, leading to challenges in obtaining population-based estimates since TGNC individuals are often unwilling to self-identify and reluctant to participate in traditional surveys. Further, past TGNC research has primarily focused on mental health, substance use and abuse, and sexual transmitted infections and diseases. There is limited data available on age-related chronic conditions such as cancer, the second leading cause of death in the United States. Nonetheless, cancer is one of the top research priorities among the TGNC population. With a rapidly growing aging TGNC population, there is an urgent need to characterize the cancer burden among these individuals and understand how cancer impact them differentially compared to non-TGNC individuals. On the other hand, rapid adoption of electronic health record (EHR) systems has made longitudinal clinical data available for research. EHRs contain not only important structured data, such as demographics, diagnoses, procedures, and medications, but also unstructured clinical narratives such as physician’s notes. More than 80 percent of the clinical information is documented in clinical narratives, which contain more detailed patient information including gender identity and cancer risk factors. Motivated by these observations and built upon our previous studies on 1) the adequacy of TGNC gender identity terms, 2) clinical natural language processing methods for information extraction, and 3) EHR-based cohort studies, we propose to conduct a population-based cohort analysis to examine the cancer burden and risk factors among TGNC people using a unique data source from a large network of EHRs—OneFlorida, one of the 13 PCORI-funded clinical data research networks (CDRNs) contributing to the PCORnet. Using both structured and unstructured OneFlorida data, we will first develop computable phenotypes to identify TGNC individuals and subsequently evaluate their cancer risk. Our research is significant because: 1) no population-based cohort studies on cancer risk have been conducted among the TGNC population. Our results will support the development of tailored, evidence- based cancer screening programs for TGNC people; 2) our research will create a cohort of TGNC people that can be not only tracked longitudinally in EHR but also recruited for future clinical studies; and 3) working with a PCORnet CDRN makes our analysis framework generalizable to the overall PCORNet. Overall, the proposed research will advance our knowledge in cancer among the aging TGNC population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation System
Disparities of Alzheimer's disease progression in sexual and gender minorities
  • 批准号:
    10590413
  • 项目类别:
  • 资助金额:
    $80.96万
  • 财政年份:
    2023
  • 负责人:
    Jiang Bian
  • 依托单位:
Artificial Intelligence and Counterfactually Actionable Responses to End HIV (AI-CARE-HIV)
  • 批准号:
    10699171
  • 项目类别:
  • 资助金额:
    $73.14万
  • 财政年份:
    2023
  • 负责人:
    Jiang Bian
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: